Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.51M Buy
6,909
+739
+12% +$253K 0.38% 34
2026
Q1
$2.17M Sell
6,170
-107
-2% -$38.1K 0.43% 33
2025
Q4
$2.06M Buy
6,277
+238
+4% +$75.5K 0.48% 32
2025
Q3
$1.71M Buy
6,039
+222
+4% +$64.4K 0.36% 42
2025
Q2
$1.7M Buy
5,817
+311
+6% +$88.1K 0.41% 34
2025
Q1
$1.7M Buy
5,506
+4,279
+349% +$1.26M 0.52% 32
2024
Q4
$320K Buy
1,227
+118
+11% +$35K 0.1% 96
2024
Q3
$357K Buy
+1,109
New +$363K 0.12% 84

Other funds holding AMGN

ORG Wealth Partners's AMGN Position: Q2 2026 in Review

ORG Wealth Partners increased its Amgen (AMGN) stake by 12% in Q2 2026, buying an estimated $253K and bringing the position to 6,909 shares worth $2.51M. The position accounts for 0.38% of the portfolio, ranked #34.

ORG Wealth Partners first reported a position in AMGN in Q3 2024 and has held it in 8 quarters since. 1,543 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • ORG Wealth Partners held 6,909 shares of Amgen worth $2.51M as of Q2 2026.
  • ORG Wealth Partners bought 739 Amgen shares in Q2 2026, an estimated $253K.
  • Amgen made up 0.38% of ORG Wealth Partners's portfolio in Q2 2026, its #34 holding.
  • ORG Wealth Partners first reported a position in Amgen in Q3 2024 and has held it in 8 quarters since.
  • 1,543 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on ORG Wealth Partners's 13F filing for Q2 2026, filed 27 Jul 2026.